The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
The VPH institute has its origins in a European Commission endorsed research area on computer modelling and simulation and has been active for over 10 years.
This partnership of industry and academia allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market.
NEWS
News
Introducing the plain language in silico medicine glossary
As in silico medicine continues to advance, new concepts and terms emerge rapidly—often before widespread consensus is established. To make this transformative field more accessible to all the stakeholders including the patients, we are pleased to present the “Plain language in silico medicine glossary”, now published on Zenodo.
Dear Avicenna Alliance members,
As we welcome the new year, we hope you had a joyful holiday season filled with moments of relaxation and happiness with your loved ones.
